MIT-MGH team finds a new approach to cancer vaccination that yields more powerful T cells
Peer-Reviewed Publication
Updates every hour. Last Updated: 29-Oct-2026 05:16 ET (29-Oct-2026 09:16 GMT/UTC)
MIT engineers developed a new way to amplify the T cell response to mRNA vaccines, using an mRNA adjuvant. This approach could lead to much more powerful cancer vaccines and stronger protection against infectious diseases.
Researchers at the University of Pennsylvania have developed ApexGO, an AI-powered method for improving promising but imperfect antibiotic candidates. Unlike many AI approaches that screen databases for molecules that might work, ApexGO starts with a small number of starter molecules and makes step-by-step edits, using a predictive algorithm to guide the search toward stronger versions. In tests against disease-causing bacteria, 85% of the AI-generated molecules halted bacterial growth, while 72% outperformed the peptides from which they were derived. The work points toward a more systematic approach to antibiotic discovery, using AI to guide researchers toward molecules most worth testing.
Researchers have developed artificial intelligence (AI) models that can scrutinize electronic health records (EHR) and electrocardiograms to identify individuals in the general population at elevated risk for sudden cardiac arrest — a condition that causes more than 400,000 U.S. deaths annually and has a survival rate of only 10%.
The finding represents a significant advance in predicting a largely unpredictable medical emergency that often strikes people with no known heart disease.
"Using artificial intelligence applications and health records data, the prediction of cardiac arrest in the general population is feasible,” said Dr. Neal Chatterjee, the study’s lead investigator and a cardiologist at the University of Washington School of Medicine.
JACC: Advances, a journal of the American College of Cardiology, published the paper today. Other co-senior authors are from Massachusetts General Hospital and the Broad Institute of MIT and Harvard.